title: Comment on "Peripheral blood used in place of bone marrow aspirate for detection of translocation t(11;14) status during minimal residual disease monitoring is cost-effectiveness".
authors.affiliation: Cetac Research Center, Caserta (CE), Italy. daniela.valente@aruba.it.
authors.forename: D
authors.initials: D
authors.lastname: Valente
authors.forename: A
authors.initials: A
authors.lastname: Rainone
mesh_terms: D001853:Bone Marrow; D003362:Cost-Benefit Analysis; D006801:Humans; D018365:Neoplasm, Residual; D016133:Polymerase Chain Reaction; D014178:Translocation, Genetic